← Eichor
Condition: Urinary Tract Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Urinary Tract Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery
NA · 1 location(s) · University of Rochester · NCT07071207
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT07416630
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Phase N/A · 1 location(s) · Origin Sciences · NCT05102110
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · 62 location(s) · UroGen Pharma Ltd. · NCT06774131
Liquid Biospy for Urinary Cancers
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06116396
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Phase 2/Phase 3 · 4 location(s) · University of British Columbia · NCT06124976
Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06689176
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Phase 2 · 9 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT04617756
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary
Phase 2/Phase 3 · 258 location(s) · National Cancer Institute (NCI) · NCT04628767
Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer
Phase N/A · 3 location(s) · University of Zurich · NCT06834152
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · 12 location(s) · MacroGenics · NCT06242470
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase 1/Phase 2 · 2 location(s) · University of Arizona · NCT06814496
Registry Platform Urologic Cancer
Phase N/A · 1 location(s) · iOMEDICO AG · NCT03374267
Fluid Challenge and Plasma Volume, During Surgery
Phase 4 · 1 location(s) · Joachim Zdolsek · NCT05726136
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05878964
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
NA · 1 location(s) · Dana-Farber Cancer Institute · NCT05899361
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · 13 location(s) · Tasca Therapeutics · NCT07030257
Infectious Complications After Cystectomy: A Prospective Observational Study
Phase N/A · 1 location(s) · Ludwig-Maximilians - University of Munich · NCT05153694
Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
Phase N/A · 2 location(s) · Jahn Ferenc South Pest Teaching Hospital · NCT06719232
The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatec
NA · 1 location(s) · Giresun University · NCT07520916
Fundación IVO Registry for Patients Undergoing Sling or Artificial Urinary Sphincter After Prostate Cancer Treatment
Phase N/A · 1 location(s) · Fundación Instituto Valenciano de Oncología · NCT02901392
Trop2-targeted immunoPET Imaging of Solid Tumors
Phase 2/Phase 3 · 1 location(s) · RenJi Hospital · NCT06851663
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bl
Phase N/A · 23 location(s) · Convergent Genomics, Inc. · NCT07673016
Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy
NA · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07558447
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma
Phase 2 · 1 location(s) · Rutgers, The State University of New Jersey · NCT06822010
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Phase 1 · 3 location(s) · Washington University School of Medicine · NCT06529822
Pre-Operative Nurse-Led Education With Direct Physiotherapy Referral to Reduce Post-Prostatectomy Incontinence
NA · 1 location(s) · Royal College of Surgeons, Ireland · NCT07426861
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774
Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
NA · 1 location(s) · The Netherlands Cancer Institute · NCT06691776
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.